Liang Shi Selected Research

Cytokines

12/2023	Effect of Infliximab on Radiation-Induced Submandibular Gland Dysfunction in Rats.
1/2022	4-Octyl itaconate regulates immune balance by activating Nrf2 and negatively regulating PD-L1 in a mouse model of sepsis.
8/2019	Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV-relative liver cirrhosis.
4/2017	Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cells.
1/2017	Inhibition of cytokine response to TLR stimulation and alleviation of collagen-induced arthritis in mice by Schistosoma japonicum peptide SJMHE1.
10/2012	Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Shi Research Topics

Disease

93	Neoplasms (Cancer) 02/2024 - 07/2009
29	Breast Neoplasms (Breast Cancer) 03/2022 - 07/2009
21	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 10/2012
18	Neoplasm Metastasis (Metastasis) 11/2023 - 06/2013
14	Inflammation (Inflammations) 03/2024 - 04/2014
14	Atrial Fibrillation 12/2023 - 08/2009
13	Stomach Neoplasms (Stomach Cancer) 05/2024 - 08/2009
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2014
10	Infections 02/2024 - 08/2006
9	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 05/2016
9	Adenocarcinoma of Lung 10/2023 - 04/2014
8	Carcinogenesis 01/2021 - 08/2009
7	Liver Neoplasms (Liver Cancer) 04/2023 - 04/2014
6	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2017
4	Lymphatic Metastasis 03/2024 - 05/2014
4	Thyroid Neoplasms (Thyroid Cancer) 03/2024 - 01/2022
4	Wounds and Injuries (Trauma) 01/2024 - 06/2013
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2016
3	Leukemia 01/2024 - 06/2018
3	Ischemia 09/2023 - 06/2014
3	Glioma (Gliomas) 07/2023 - 01/2020
3	Colitis 07/2023 - 09/2019
3	Papillary Thyroid Cancer 01/2023 - 10/2022
3	Cardiac Arrhythmias (Arrythmia) 10/2022 - 09/2014
3	Hemorrhage 01/2022 - 01/2018
3	Acute Liver Failure (Fulminant Hepatic Failure) 09/2020 - 02/2016
3	Pneumonia (Pneumonitis) 01/2020 - 05/2004
3	Hypoxia (Hypoxemia) 11/2017 - 07/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 01/2014
3	Gastritis 04/2016 - 08/2009
3	Type 2 Diabetes Mellitus (MODY) 10/2013 - 06/2006
3	Multiple Myeloma 11/2010 - 04/2010
2	Sepsis (Septicemia) 04/2024 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 01/2017
2	Postoperative Hemorrhage 11/2023 - 11/2022
2	Diabetes Mellitus 10/2023 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 09/2016
2	Osteoarthritis 08/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2005
21	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2014
18	MicroRNAs (MicroRNA)IBA 03/2024 - 01/2014
14	Messenger RNA (mRNA)IBA 01/2020 - 11/2012
11	Long Noncoding RNAIBA 03/2024 - 01/2018
10	Circular RNAIBA 11/2023 - 11/2017
7	N-methyladenosineIBA 11/2023 - 01/2019
7	RNA (Ribonucleic Acid)IBA 12/2021 - 03/2017
6	EnzymesIBA 02/2024 - 01/2017
6	CytokinesIBA 12/2023 - 10/2012
6	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 05/2014
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 06/2006
6	Cisplatin (Platino)FDA LinkGeneric 03/2019 - 01/2014
5	Anaplastic Lymphoma KinaseIBA 01/2023 - 01/2017
5	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2020 - 02/2016
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 11/2010
4	6-methyladenineIBA 01/2023 - 01/2019
4	CateninsIBA 05/2022 - 01/2017
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 02/2014
4	Competitive Endogenous RNAIBA 01/2021 - 01/2018
4	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2016
4	SaponinsIBA 02/2018 - 01/2014
4	AntioxidantsIBA 01/2017 - 01/2014
3	Therapeutic UsesIBA 05/2024 - 01/2022
3	AntibodiesIBA 04/2024 - 01/2023
3	LipidsIBA 11/2023 - 08/2009
3	Immune Checkpoint InhibitorsIBA 03/2023 - 01/2020
3	Anti-Arrhythmia AgentsIBA 10/2022 - 01/2018
3	Small Interfering RNA (siRNA)IBA 05/2022 - 08/2017
3	AntigensIBA 01/2022 - 11/2018
3	Dyneins (Dynein)IBA 01/2022 - 01/2017
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 05/2014
3	Tamoxifen FDA LinkGeneric 01/2021 - 07/2009
3	Estrogen ReceptorsIBA 01/2021 - 05/2015
3	Drug CombinationsIBA 06/2020 - 01/2018
3	Interleukin-10 (Interleukin 10)IBA 09/2019 - 08/2013
3	Gemcitabine FDA Link 11/2018 - 06/2013
3	TriterpenesIBA 01/2018 - 01/2014
3	Protein Isoforms (Isoforms)IBA 01/2018 - 03/2017
3	InterferonsIBA 01/2017 - 10/2012
3	Peptides (Polypeptides)IBA 01/2017 - 08/2009
2	itaconic acidIBA 04/2024 - 07/2023
2	anlotinibIBA 04/2024 - 12/2019
2	Choline (Choline Chloride)IBA 03/2024 - 05/2022
2	Bevacizumab (Avastin)FDA Link 01/2024 - 01/2018
2	IronIBA 12/2023 - 01/2023
2	Amino Acids FDA Link 10/2023 - 01/2022
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2023 - 01/2020
2	IodineIBA 06/2023 - 10/2022
2	4-octyl itaconateIBA 03/2023 - 01/2022
2	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2021
2	MethyltransferasesIBA 01/2023 - 01/2021
2	VaccinesIBA 10/2022 - 01/2022
2	KinesinsIBA 05/2022 - 01/2022

Therapy/Procedure

38	Therapeutics 05/2024 - 10/2009
16	Drug Therapy (Chemotherapy) 05/2024 - 07/2009
6	Catheter Ablation 12/2020 - 01/2018
5	Immunotherapy 01/2024 - 02/2013
4	Aftercare (After-Treatment) 01/2024 - 08/2013
4	Chemoprevention 04/2016 - 08/2009
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 05/2024